Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide

Authors

Institutions

Publication Details

Journal
The Oncologist
Published
2025-07-14
DOI
https://doi.org/10.1093/oncolo/oyaf210
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide

Bo Ding, Shiya Zheng, Shanhu Qiu, Xiang Zhao et al.
The Oncologist
Ovarian cancer diagnosis and treatment
article

Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide

Bo Ding, Shiya Zheng, Shanhu Qiu, Xiang Zhao, Feng Ji, Jingyun Xu, Hao Lin, Yang Shen, Tianxiang Yu
article en

Abstract

No abstract available for this paper.
The OncologistVol. 30(9)
Southeast University (BD), Simcere Pharmaceutical (China) (CN), Zhongda Hospital Southeast University (CN), Jiangsu Industry Technology Research Institute (CN), Southeast University (CN)
National Natural Science Foundation of China, Government of Jiangsu Province, Southeast University
Good health and well-being
Openalex Percentile: Top 76%
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.